We are live on ! Find out more
IMPL

Impel Pharmaceuticals Inc. Common Stock

Delisted

IMPL was delisted on the 15th of December, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
KKRC
1
Kohlberg Kravis Roberts & Co
New York
$20.1M
5VM
2
5AM Venture Management
California
$14M
VC
3
Vivo Capital
California
$14M
VP
4
venBio Partners
California
$13.4M
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.5M
DA
6
DCF Advisers
Connecticut
$2.29M +$234K +30,617 +7%
LM
7
Lasry Marc
$1.99M
OM
8
Opaleye Management
Massachusetts
$1.24M +$847K +110,608 +76%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$723K +$256K +33,461 +29%
GGHC
10
Gilder Gagnon Howe & Co
New York
$695K +$40.6K +5,302 +4%
LCM
11
Laurion Capital Management
New York
$608K
BlackRock
12
BlackRock
New York
$523K +$74.9K +9,783 +10%
BCM
13
Bridgeway Capital Management
Texas
$333K -$76.6K -10,000 -13%
State Street
14
State Street
Massachusetts
$203K
Bank of New York Mellon
15
Bank of New York Mellon
New York
$172K +$2.08K +271 +0.8%
Millennium Management
16
Millennium Management
New York
$155K -$860K -112,365 -78%
E
17
Ergoteles
New York
$119K -$30.3K -3,953 -14%
EP
18
EPIQ Partners
Minnesota
$91K
Renaissance Technologies
19
Renaissance Technologies
New York
$85K +$1.53K +200 +1%
BJL
20
Brighton Jones LLC
Washington
$69K
TFS
21
TrustCore Financial Services
Tennessee
$65K
Northern Trust
22
Northern Trust
Illinois
$65K +$24K +3,135 +31%
Citadel Advisors
23
Citadel Advisors
Florida
$64K +$101K +13,217 New
Morgan Stanley
24
Morgan Stanley
New York
$55K -$31.7K -4,147 -26%
Goldman Sachs
25
Goldman Sachs
New York
$55K -$23.5K -3,065 -21%